Rhumbline Advisers Astrazeneca PLC Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Astrazeneca PLC stock. As of the latest transaction made, Rhumbline Advisers holds 29,064 shares of AZN stock, worth $2.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,064
Previous 28,142
3.28%
Holding current value
$2.48 Million
Previous $2.07 Million
1.84%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,412Shares Held
496MCall Options Held
7.11MPut Options Held
2.56M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.43 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.52 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.93 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.68 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.66 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $265B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...